Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-23-016507

Chief Accounting Officer & VP sold 1,871 shares at $0.98 ($1,834)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Monohon Ted Chief Accounting Officer & VP 2023-03-06 Sale −1,871 $0.98 $1,834 27,440 D
Open-market sales · 1,871 sh · avg $0.98 · $1,834
Loading xslF345X03/doc4.xml…